{
    "2019-05-05": [
        [
            {
                "time": "",
                "original_text": "【西南医药】医药行业2018年年报及2019年一季报总结：行业分化明显，疫苗、CRO和药店等表现抢眼",
                "features": {
                    "keywords": [
                        "医药行业",
                        "年报",
                        "一季报",
                        "行业分化",
                        "疫苗",
                        "CRO",
                        "药店"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "板块分化后的投资策略 ——兴证医药2019年5月投资月报",
                "features": {
                    "keywords": [
                        "板块分化",
                        "投资策略",
                        "兴证医药",
                        "投资月报"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【上海医药】Q1点评：工商协同发力，全新上药再起航",
                "features": {
                    "keywords": [
                        "上海医药",
                        "Q1点评",
                        "工商协同",
                        "全新上药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "286家药企一季度成绩单出炉！白云山、恒瑞……净利润超10亿，这9家毛利率超90%",
                "features": {
                    "keywords": [
                        "药企",
                        "一季度",
                        "白云山",
                        "恒瑞",
                        "净利润",
                        "毛利率"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【国盛医药张金洋团队】年报季报验证医药从野蛮扩张到结构优化，继续推荐医药流通",
                "features": {
                    "keywords": [
                        "国盛医药",
                        "年报季报",
                        "野蛮扩张",
                        "结构优化",
                        "医药流通"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "11家药企研发投入破10亿！4家超过20亿",
                "features": {
                    "keywords": [
                        "药企",
                        "研发投入",
                        "10亿",
                        "20亿"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中成药企业连爆丑闻；4名药企董事长月末辞职… | 魔方高调周报",
                "features": {
                    "keywords": [
                        "中成药",
                        "丑闻",
                        "董事长辞职",
                        "魔方高调周报"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "上海医药一季度净利11.26亿元 同比增长10% 现金流量净额为1.54亿元",
                "features": {
                    "keywords": [
                        "上海医药",
                        "一季度",
                        "净利",
                        "同比增长",
                        "现金流量净额"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}